KR900011757A - 피리디늄 니트레이트, 그의 제조방법 및 용도 - Google Patents

피리디늄 니트레이트, 그의 제조방법 및 용도 Download PDF

Info

Publication number
KR900011757A
KR900011757A KR1019900001020A KR900001020A KR900011757A KR 900011757 A KR900011757 A KR 900011757A KR 1019900001020 A KR1019900001020 A KR 1019900001020A KR 900001020 A KR900001020 A KR 900001020A KR 900011757 A KR900011757 A KR 900011757A
Authority
KR
South Korea
Prior art keywords
compound
formula
general formula
following general
inhibiting
Prior art date
Application number
KR1019900001020A
Other languages
English (en)
Other versions
KR0143413B1 (ko
Inventor
스스무 쓰시마
무네오 다까따니
고오헤이 니시까와
Original Assignee
우메모또 요시마사
다께다야꾸힝 고오교 가부시끼가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 우메모또 요시마사, 다께다야꾸힝 고오교 가부시끼가이샤 filed Critical 우메모또 요시마사
Publication of KR900011757A publication Critical patent/KR900011757A/ko
Application granted granted Critical
Publication of KR0143413B1 publication Critical patent/KR0143413B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

내용 없음

Description

피리디늄 니트레이트, 그의 제조방법 및 용도
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음

Claims (5)

  1. 하기 일반식(I)의 화합물.
  2. (a)활성 성분으로서, 혈소판 활성화 인자의 활성을 억제하기 위한 유효량의 제1항에 다르는 화합물, 및 (b)제약학적으로 허용 가능한 담체 또는 부형제를 함유함을 특징으로 하는, 혈소판 활성화 인자의 활성을 억제하는데 적합한 제약학적 조성물.
  3. 혈소판 활성화 인자의 활성을 억제하기 위한 유효량의 제1항 화합물을 포유 동물에 투여함을 특징으로하는 포유 동물의 혈소판 활성화 인자의 활성 억제 방법.
  4. 제1항에 따르는 화합물의 포유 동물의 치료처지를 위한 용도.
  5. I)하기 일반식(II)의 화합물을 하기 일반식(III)의 화합물과 반응시킨 후 NO3-이온을 도입하거나,
    [상기 식중, Q1는 질소 원자에 용이하게 치환되는 기를 나타낸다.] II)하기 일반식(IV)의 화합물과 하기 일반식(V)의 화합물을 탈수 축합시키거나,
    III)하기 일반식(VI)의 화합물과 하기 일반식(VII)의 화합물을 탈수 축합시키거나,
    IV)하기 일반식(VIII)의 화합물을 하기 일반식(IX)의 화합물과 반응시키거나,
    [상기 식중, G는 할로게노 또는 페녹시기이다.]
    V)하기 일반식(X)의 화합물을 하기 일반식(XI)의 화합물과 반응시키는 것을 특징으로 하는 제1항의 화합물의 제조방법.
    [상기 식중, G는 할로게노 또는 페녹시기이다.]
    ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
KR1019900001020A 1989-01-30 1990-01-30 피리디늄 니트 레이트, 그의 제조방법 및 용도 KR0143413B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP021919-1989 1989-01-30
JP1-21919 1989-01-30
JP2191989 1989-01-30

Publications (2)

Publication Number Publication Date
KR900011757A true KR900011757A (ko) 1990-08-02
KR0143413B1 KR0143413B1 (ko) 1998-07-15

Family

ID=12068486

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019900001020A KR0143413B1 (ko) 1989-01-30 1990-01-30 피리디늄 니트 레이트, 그의 제조방법 및 용도

Country Status (9)

Country Link
US (1) US4981860A (ko)
EP (1) EP0382380B1 (ko)
JP (1) JP2765155B2 (ko)
KR (1) KR0143413B1 (ko)
AT (1) ATE93855T1 (ko)
CA (1) CA2008771C (ko)
DE (1) DE69002959T2 (ko)
DK (1) DK0382380T3 (ko)
ES (1) ES2058779T3 (ko)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2068742B1 (es) * 1993-02-11 1995-11-16 Uriach & Cia Sa J Nuevos derivados de piridinio.
US5496855A (en) * 1995-01-27 1996-03-05 Smithkline Beecham Corp. Anti-inflammatory compounds
AU5514196A (en) * 1995-04-27 1996-11-18 Takeda Chemical Industries Ltd. Agent for severe acute pancreatitis
WO1998004547A1 (en) * 1996-07-25 1998-02-05 Takeda Chemical Industries, Ltd. Crystalline pyridinium derivatives as paf-antagonists

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK160818C (da) * 1983-12-30 1991-10-07 Hoffmann La Roche N-ring-holdige glycerolderivater, fremgangsmaade til fremstilling deraf, anvendelse deraf til fremstilling af et blodpladeaktiveringsfaktorhaemmende middel samt laegemidler indeholdende en saadan forbindelse
DE3879024T2 (de) * 1987-07-31 1993-10-07 Takeda Chemical Industries Ltd Pyridinium-Derivate, ihre Herstellung und Verwendung.

Also Published As

Publication number Publication date
ATE93855T1 (de) 1993-09-15
KR0143413B1 (ko) 1998-07-15
EP0382380B1 (en) 1993-09-01
EP0382380A1 (en) 1990-08-16
US4981860A (en) 1991-01-01
DE69002959D1 (de) 1993-10-07
DE69002959T2 (de) 1994-03-24
JP2765155B2 (ja) 1998-06-11
DK0382380T3 (da) 1994-01-10
JPH02275876A (ja) 1990-11-09
CA2008771A1 (en) 1990-07-30
ES2058779T3 (es) 1994-11-01
CA2008771C (en) 1999-03-23

Similar Documents

Publication Publication Date Title
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
FR2692264B1 (fr) Nouvelles piperazines 1,4-disubstituees, leur procede de preparation et les compositions pharmaceutiques les contenant.
ES2064461T3 (es) Derivados de xantina, procedimiento para su preparacion y composicion farmaceutica.
SE8404065D0 (sv) Novel biologically active compounds
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
DK656488D0 (da) Praeparat med langvarig frigivelse indeholdende 1,4-dihydropyridinforbindelser
ATE48001T1 (de) Cephemverbindungen, verfahren zu ihrer herstellung und ihre pharmazeutischen praeparate.
EP0327709A3 (en) Novel platinum complex, antineoplastic agent containing the same, intermediate therefor, preparation method and use
KR880009018A (ko) 3-l-피로글루타밀-l-티아졸리딘-4-카르복실산 및 이의 제법
KR900014406A (ko) 세펨 화합물 및 이의 제조방법
SE8600658D0 (sv) Novel composition of matter
KR910009259A (ko) 천식 또는 특정 피부 질환의 치료를 위한 피리미돈 유도체 및 동족체
KR900011757A (ko) 피리디늄 니트레이트, 그의 제조방법 및 용도
KR920007995A (ko) 벤즈아미드 유도체
KR910007881A (ko) 아미노피리디닐아미노페놀 및 관련화합물, 이들의 제조방법 및 중간체 및 약제로서의 이들의 용도
KR880007070A (ko) 백내장 치료용 약학 조성물
NO913023L (no) Nye bicykliske aminosubstituerte forbindelser
KR890003755A (ko) 7- (2- 메틸- 4- 아미노피롤리디닐)나프티리딘 및 퀴놀린 화합물
KR880004810A (ko) 소화성 궤양 치료제
FI903701A0 (fi) Reninhaemmande amino-oligohydroxiderivat.
KR920002594A (ko) 5-이소티아졸아민 유도체
FR2655042B1 (fr) Nouvelles benzothiazolinones substituees, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
KR940005610A (ko) 신규한 피페리딘 유도체 및 이의 제조방법
KR870001153A (ko) 디페녹시에틸아민 유도체가 함유된 약제조성물 및 그의 생산방법

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee